Fig. 1 · Structure
Documents & Downloads
Treprostinil palmitil
Pulmonary Vasodilator Prodrug
Treprostinil palmitil is a long-acting pulmonary vasodilator prodrug that targets the inhibition of hypoxia-induced pulmonary vasoconstriction. Formulated in lipid nanoparticles, it exhibits sustained lung presence while minimizing systemic exposure. Research applications include the investigation of pulmonary arterial hypertension and interstitial lung disease, as well as the capacity to inhibit pulmonary vascular remodeling induced by Su/Hx challenge in animal models. Additionally, Treprostinil palmitil is associated with cough induction.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| CAS Number | 1706528-83-7 |
| Applications | Pulmonary Vasodilator Prodrug |
| Formula | C39H66O5 |
| Molecular Weight | 614.94 |
| Synonyms | INS-1009 |
| SMILES | CCCCC[C@H](O)CC[C@@H]1[C@]2([H])[C@@](C[C@H]1O)([H])CC3=C(OCC(OCCCCCCCCCCCCCCCC)=O)C=CC=C3C2 |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.